v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 12 $ 788,697 $ (697,578) $ 91,131
Balance, shares at Dec. 31, 2023 114,963,193      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   4,870   4,870
Issuance of common stock upon exercise of stock options, shares 1,025,384      
Issuance of common stock upon vesting of restricted stock units (in shares) 532,717      
Issuance of common stock upon exercise of pre-funded warrants $ 3 316,350   316,353
Issuance of common stock upon exercise of pre-funded warrants, shares 32,413,560      
Issuance of common stock in connection with conversion of Convertible Notes   52,499   52,499
Issuance of common stock in connection with conversion of Convertible Notes, shares 5,769,232      
Stock-based compensation expense   7,978   7,978
Net Income (Loss)     (64,848) (64,848)
Balance at Mar. 31, 2024 $ 15 1,170,394 (762,426) 407,983
Balance, shares at Mar. 31, 2024 154,704,086      
Balance at Dec. 31, 2023 $ 12 788,697 (697,578) 91,131
Balance, shares at Dec. 31, 2023 114,963,193      
Stockholders' Equity (Deficit)        
Net Income (Loss)       (108,625)
Balance at Jun. 30, 2024 $ 16 1,183,882 (806,203) 377,695
Balance, shares at Jun. 30, 2024 155,624,363      
Balance at Mar. 31, 2024 $ 15 1,170,394 (762,426) 407,983
Balance, shares at Mar. 31, 2024 154,704,086      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options $ 1 1,703   1,704
Issuance of common stock upon exercise of stock options, shares 245,554      
Issuance of common stock in connection with employee stock purchase plan   492   492
Issuance of common stock in connection with employee stock purchase plan, shares 120,806      
Issuance of common stock upon vesting of restricted stock units (in shares) 553,917      
Stock-based compensation expense   11,293   11,293
Net Income (Loss)     (43,777) (43,777)
Balance at Jun. 30, 2024 $ 16 1,183,882 (806,203) 377,695
Balance, shares at Jun. 30, 2024 155,624,363      
Balance at Dec. 31, 2024 $ 16 1,206,412 (891,084) 315,344
Balance, shares at Dec. 31, 2024 157,749,490      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   4,183   4,183
Issuance of common stock upon exercise of stock options, shares 880,115      
Issuance of common stock upon vesting of restricted stock units (in shares) 632,419      
Stock-based compensation expense   10,456   10,456
Net Income (Loss)     (64,053) (64,053)
Balance at Mar. 31, 2025 $ 16 1,221,051 (955,137) 265,930
Balance, shares at Mar. 31, 2025 159,262,024      
Balance at Dec. 31, 2024 $ 16 1,206,412 (891,084) 315,344
Balance, shares at Dec. 31, 2024 157,749,490      
Stockholders' Equity (Deficit)        
Net Income (Loss)       (131,867)
Balance at Jun. 30, 2025 $ 17 1,328,850 (1,022,951) 305,916
Balance, shares at Jun. 30, 2025 172,925,389      
Balance at Mar. 31, 2025 $ 16 1,221,051 (955,137) 265,930
Balance, shares at Mar. 31, 2025 159,262,024      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   3,384   3,384
Issuance of common stock upon exercise of stock options, shares 697,692      
Issuance of common stock in connection with employee stock purchase plan   713   713
Issuance of common stock in connection with employee stock purchase plan, shares 96,007      
Issuance of common stock upon vesting of restricted stock units (in shares) 229,154      
Issuance of common stock upon exercise of pre-funded warrants, shares 1,092,148      
Issuance of common stock upon public offering, net of issuance costs $ 1 94,024   94,025
Issuance of common stock upon public offering, net of issuance costs, shares 11,548,364      
Stock-based compensation expense   9,678   9,678
Net Income (Loss)     (67,814) (67,814)
Balance at Jun. 30, 2025 $ 17 $ 1,328,850 $ (1,022,951) $ 305,916
Balance, shares at Jun. 30, 2025 172,925,389